USBC stock analysis
Want to see USBC full AI Analyst Report?
USBC (USBC) Stock Price & Analysis
USBC Stock Chart & Stats
- Day’s Range
- $0.34 - $0.36
- 52-Week Range
- $0.29 - $0.91
- Previous Close
- $0.36
- Volume
- N/A
- Average Volume (3M)
- 162.09K
- Market Cap
- $140.28M
- Enterprise Value
- $133.04M
- Total Cash (Recent Filing)
- $3.47B
- Total Debt (Recent Filing)
- $172.24M
- Price to Earnings (P/E)
- ―
- Beta
- 2.34
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Conservative Recent Leverage
Recent leverage appears conservative, which can preserve financial flexibility and reduce interest burden relative to a highly indebted structure. If maintained, this gives USBC more capacity to manage volatility, support operations, and pursue its stated initiatives without excessive reliance on debt.
Expanded Borrowing Capacity
The larger credit facility provides additional potential liquidity for working capital and corporate needs over the coming months. Although collateral requirements create risk, access to committed borrowing capacity may help USBC fund operations and reduce immediate dependence on internally generated cash.
Experienced CFO Appointment
Appointing a CFO with experience at SVB Financial Group, Silicon Valley Bank, BancWest, and Bank of the West could strengthen financial oversight as USBC develops tokenized deposits and manages complex funding arrangements. The transition may improve institutional financial leadership.
Bears Say
Persistent Operating Losses
Repeated operating and net losses indicate that USBC has not yet demonstrated a durable, profitable core business model. Continued losses can consume capital, constrain reinvestment, and make future performance increasingly dependent on external financing or non-operating gains rather than recurring operations.
Sustained Cash Burn
Persistent negative operating and free cash flow show that the business is not currently self-funding. This weakens financial resilience because USBC may need additional capital to maintain operations and develop products, while the gap between reported income and cash generation raises earnings-quality concerns.
Collateral And Related-Party Financing Risk
USBC relies on financing structures that add material governance and balance-sheet risk. Bitcoin collateral is subject to margin and liquidation requirements, while CEO-controlled lending creates related-party exposure, potentially increasing refinancing, conflict-of-interest, and shareholder oversight concerns.
USBC News
USBC FAQ
What was USBC’s price range in the past 12 months?
What is USBC’s market cap?
When is USBC’s upcoming earnings report date?
How were USBC’s earnings last quarter?
Is USBC overvalued?
Does USBC pay dividends?
What is USBC’s EPS estimate?
How many shares outstanding does USBC have?
What happened to USBC’s price movement after its last earnings report?
Which hedge fund is a major shareholder of USBC?
What is the TipRanks Smart Score and how is it calculated?
USBC Stock Smart Score
Company Description
USBC
USBC, Inc., along with its affiliated companies, operates within the digital financial technology industry across the United States. The firm is dedicated to creating groundbreaking financial services, such as digital assets and advanced banking solutions. Additionally, USBC undertakes research in the field of non-invasive health monitoring. Another significant aspect of its operations involves employing electromagnetic energy to identify, measure, and analyze the distinct signatures of various materials or analytes. Originally incorporated in 1998, the company is headquartered in Reno, Nevada. It was previously known as Know Labs, Inc., and is scheduled to formally adopt the name USBC, Inc. in August 2025.
- Sector
- Technology
- Industry
- Hardware, Equipment & Parts
- CEO
- Robert Gregory Kidd
- Employees
- 24
- Website
- investors.usbc.xyz
- Address
- 300 E 2nd Street, Reno, NV, 89501, US
USBC (USBC) Earnings & Revenues
USBC Earnings Call
Earnings Call SentimentNeutral
The earnings call presented a mix of promising technological advancements and clinical results, coupled with financial challenges and a need for further capital. The company is making significant strides in product development and intellectual property, but faces issues with cash reserves and shareholder equity.
View all USBC earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |













